(Q41155680)

English

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

scientific article published on 2 November 2015

Statements

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study (English)
Armand de Gramont
Benoist Chibaudel
Annemilaï Tijeras-Raballand
Aurelie Scriva
Tamas Hickish
Jean Luc Van Laethem
Maria Banzi
Eduard Maartense
Einat Shmueli
Goran U Carlsson
Werner Scheithauer
Demetris Papamichael
Marcus Möehler
Pieter Demetter
Soudhir Colote
Christophe Tournigand
Christophe Louvet
Alex Duval
Aimery de Gramont
2 November 2015
4176-4187

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit